Exercise capacity in atrial fibrillation: A substudy of the Sotalol-Amiodarone Atrial Fibrillation Efficacy Trial (SAFE-T)

To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.ahj.2006.12.020 Byline: J. Edwin Atwood (a), Jonathan N. Myers (e), X. Charlene Tang (d), Domenic J. Reda (d), Steven N. Singh (b), Bramah N. Singh (c) Abstract: Therapy for chronic atrial fibrillation (AF) focuses on rate versus rhythm control, but little is known about the effects of common therapeutic interventions on exercise tolerance in AF. Author Affiliation: (a) Walter Reed Army Medical Center, Washington, DC (b) Department of Veterans Affairs Medical Center, Washington, DC (c) Department of Veterans Affairs Medical Center, Los Angeles, CA (d) Department of Veterans Affairs Medical Center, Hines, IL (e) Department of Veterans Affairs Medical Center, Palo Alto, CA Article History: Received 12 April 2006; Accepted 17 December 2006 Article Note: (footnote) This study was supported by the Cooperative Studies Program of the Department of Veterans Affairs Office of Research and Development (Washington, DC), Berlex Laboratories (Montville, IL) and Wyeth-Ayerst Laboratories (Philadelphia, PA).